持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/07 | 4,065 | 4,090 | 4,005 | 4,030 | -120 | -2.9% | 68,900 |
2020/05/01 | 4,220 | 4,235 | 4,145 | 4,150 | -50 | -1.2% | 43,700 |
2020/04/30 | 4,225 | 4,250 | 4,180 | 4,200 | -20 | -0.5% | 67,900 |
2020/04/28 | 4,185 | 4,235 | 4,120 | 4,220 | +60 | +1.4% | 50,700 |
2020/04/27 | 4,150 | 4,180 | 4,080 | 4,160 | +60 | +1.5% | 52,800 |
2020/04/24 | 4,120 | 4,145 | 4,045 | 4,100 | -10 | -0.2% | 63,200 |
2020/04/23 | 4,090 | 4,125 | 4,030 | 4,110 | +105 | +2.6% | 48,100 |
2020/04/22 | 4,020 | 4,035 | 3,955 | 4,005 | -15 | -0.4% | 44,100 |
2020/04/21 | 4,075 | 4,110 | 3,995 | 4,020 | -50 | -1.2% | 43,900 |
2020/04/20 | 4,110 | 4,185 | 4,070 | 4,070 | -55 | -1.3% | 33,400 |
2020/04/17 | 4,235 | 4,235 | 4,095 | 4,125 | -40 | -1% | 46,000 |
2020/04/16 | 4,130 | 4,230 | 4,080 | 4,165 | +20 | +0.5% | 55,900 |
2020/04/15 | 4,235 | 4,235 | 4,050 | 4,145 | -90 | -2.1% | 132,400 |
2020/04/14 | 4,335 | 4,360 | 4,205 | 4,235 | -95 | -2.2% | 85,200 |
2020/04/13 | 4,390 | 4,415 | 4,295 | 4,330 | -65 | -1.5% | 44,500 |
2020/04/10 | 4,265 | 4,395 | 4,160 | 4,395 | +145 | +3.4% | 52,700 |
2020/04/09 | 4,215 | 4,290 | 4,145 | 4,250 | +20 | +0.5% | 53,900 |
2020/04/08 | 4,075 | 4,270 | 4,045 | 4,230 | +155 | +3.8% | 102,400 |
2020/04/07 | 3,985 | 4,095 | 3,940 | 4,075 | +40 | +1% | 77,900 |
2020/04/06 | 3,890 | 4,060 | 3,825 | 4,035 | +250 | +6.6% | 70,100 |
2020/04/03 | 3,815 | 3,915 | 3,740 | 3,785 | +10 | +0.3% | 62,500 |
2020/04/02 | 3,885 | 3,985 | 3,765 | 3,775 | -145 | -3.7% | 78,500 |
2020/04/01 | 4,110 | 4,265 | 3,920 | 3,920 | -250 | -6% | 90,200 |
2020/03/31 | 4,375 | 4,435 | 4,135 | 4,170 | -410 | -9% | 136,000 |
2020/03/30 | 4,505 | 4,590 | 4,350 | 4,580 | -10 | -0.2% | 135,200 |
2020/03/27 | 4,460 | 4,590 | 4,365 | 4,590 | +200 | +4.6% | 153,400 |
2020/03/26 | 4,145 | 4,410 | 4,030 | 4,390 | +235 | +5.7% | 141,200 |
2020/03/25 | 4,095 | 4,195 | 4,000 | 4,155 | +155 | +3.9% | 87,500 |
2020/03/24 | 4,175 | 4,175 | 3,855 | 4,000 | -105 | -2.6% | 92,400 |
2020/03/23 | 4,300 | 4,395 | 3,915 | 4,105 | -75 | -1.8% | 174,800 |
2020/03/19 | 4,080 | 4,270 | 4,055 | 4,180 | +275 | +7% | 215,200 |
2020/03/18 | 3,655 | 4,350 | 3,630 | 3,905 | +255 | +7% | 222,500 |
2020/03/17 | 3,200 | 3,700 | 3,180 | 3,650 | +400 | +12.3% | 143,600 |
2020/03/16 | 3,295 | 3,445 | 3,245 | 3,250 | +20 | +0.6% | 109,100 |
2020/03/13 | 3,245 | 3,285 | 3,080 | 3,230 | -225 | -6.5% | 148,400 |
2020/03/12 | 3,565 | 3,590 | 3,425 | 3,455 | -200 | -5.5% | 108,500 |
2020/03/11 | 3,590 | 3,715 | 3,590 | 3,655 | +30 | +0.8% | 97,900 |
2020/03/10 | 3,615 | 3,660 | 3,475 | 3,625 | -20 | -0.5% | 110,700 |
2020/03/09 | 3,695 | 3,755 | 3,605 | 3,645 | -140 | -3.7% | 64,000 |
2020/03/06 | 3,820 | 3,835 | 3,780 | 3,785 | -90 | -2.3% | 57,600 |
2020/03/05 | 3,850 | 3,905 | 3,825 | 3,875 | +115 | +3.1% | 54,100 |
2020/03/04 | 3,750 | 3,835 | 3,705 | 3,760 | -55 | -1.4% | 67,200 |
2020/03/03 | 3,940 | 3,955 | 3,815 | 3,815 | -55 | -1.4% | 71,000 |
2020/03/02 | 3,710 | 3,885 | 3,710 | 3,870 | +75 | +2% | 78,300 |
2020/02/28 | 3,825 | 3,865 | 3,785 | 3,795 | -145 | -3.7% | 74,500 |
2020/02/27 | 3,980 | 3,980 | 3,920 | 3,940 | -50 | -1.3% | 68,200 |
2020/02/26 | 4,030 | 4,030 | 3,950 | 3,990 | -75 | -1.8% | 76,700 |
2020/02/25 | 4,110 | 4,135 | 4,065 | 4,065 | -210 | -4.9% | 76,000 |
2020/02/21 | 4,240 | 4,305 | 4,240 | 4,275 | +15 | +0.4% | 35,200 |
2020/02/20 | 4,260 | 4,320 | 4,260 | 4,260 | -10 | -0.2% | 38,900 |
1301~
1350
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 311,500円 | +7.9% | -3.3% | 2.57% | 8.66倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム